NAPROXEN SODIUM

Product NDC
46994-665
Requested package NDC
46994-665-50
11-digit product format
469940665
Labeler code
46994
Product ID
46994-665_ee27e839-4bee-2d01-e053-2995a90a82ce
Type
HUMAN OTC DRUG
Nonproprietary name
NAPROXEN SODIUM
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Labeler
SAVE-A-LOT FOOD STORES, LTD.
Application
ANDA091353
Marketing category
ANDA
Marketing start
2022-08-24
Marketing end
0000-00-00
Substance
NAPROXEN SODIUM
Active strength
220 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage46994-66546994-665-50DDiscontinued by firm2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 15 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Code, Status table
Captured / source dateCodeStatusSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05DDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26DDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31DDiscontinued by firm2ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28DDiscontinued by firma1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21DDiscontinued by firmcfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10DDiscontinued by firmcdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31DDiscontinued by firm302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20DDiscontinued by firmed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10DDiscontinued by firm0efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08IInactivated by FDAad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03IInactivated by FDA367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09IInactivated by FDA557ba5c1ecfa…9c80585c8c6e…
2024-05-28 21:12 UTC · source 2024-05-28IInactivated by FDA8af77b9d5b6f…d9bbb34c5368…
2024-05-15 03:39 UTC · source 2024-05-14IInactivated by FDA834df4deac94…adcc014656a3…
2024-03-11 06:39 UTC · source 2024-03-08IInactivated by FDA1332a3947898…d4bfe170f9cd…

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A091353-001NAPROXEN SODIUMNAPROXEN SODIUM220MGTABLET / ORAL2011-09-20

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-20caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-20011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-2031067a03dcf5…
2025-08-23 18:47 UTC2025-08A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-206a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-20fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-20b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-2003ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-202680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-205bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-20d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-20d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-2079d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-20301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-201e350fbaab3a…
2024-05-31 18:47 UTC2024-05A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-208072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-205c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-205d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-204b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-2074a2ff9319b5…
2022-03-09 01:35 UTC2022-03A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-20bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-20782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-2087673890dc5c…
2021-03-12 10:30 UTC2021-03A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-205aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-208869cabd3fbd…
2020-11-12 02:37 UTC2020-11A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-20c0c555d07b60…
2019-12-14 00:12 UTC2019-12A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-203f01610625f2…
2019-09-15 20:21 UTC2019-09A091353-001NAPROXEN SODIUMEQ 200MG BASETABLET / ORAL2011-09-20b00525d2431f…
2019-07-19 19:46 UTC2019-07A091353-001NAPROXEN SODIUMEQ 200MG BASETABLET / ORAL2011-09-20ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-206a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-201c564ffb4f44…
2023-12-20 04:57 UTC2023-12A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-20ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-20a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-209b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-20a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-203f0d92c62455…
2023-05-13 08:27 UTC2023-05A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-20053a50430f4f…
2023-01-26 05:58 UTC2023-01A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-203bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-203a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-20f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A091353-001NAPROXEN SODIUM220MGTABLET / ORAL2011-09-20e64feba35796…

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
46994-665-502024-01-30C16284748780-11030e365-6c03-111a-e063-dadaa90a10e2NAPROXEN SODIUM TABLETS

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 14 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Rapidol NaproxenNAPROXEN SODIUMPharmadel LLCc94c4b6e-a48b-cee5-e053-2995a90a49ac2026-03-20WarningsExact identifier
application applno (ANDA): 091353
application number: ANDA091353
Naproxen SodiumNAPROXEN SODIUMGranules USA, Inc.8cb8030c-b281-315c-e053-2a95a90a36f02025-12-22WarningsExact identifier
application applno (ANDA): 091353
application number: ANDA091353
NaproxenNAPROXENSafeway, Incf2a273f8-d623-dc2f-e053-2995a90a0c022025-12-19WarningsExact identifier
application applno (ANDA): 091353
application number: ANDA091353
Naproxen SodiumNAPROXEN SODIUMSafeway, Incf2a297c2-3898-5e47-e053-2995a90ab3cc2025-12-19WarningsExact identifier
application applno (ANDA): 091353
application number: ANDA091353
Naproxen SodiumNAPROXEN SODIUMTARGET CORPORATIONfdb87abd-3176-dd62-e053-6394a90a6fcc2025-12-19WarningsExact identifier
application applno (ANDA): 091353
application number: ANDA091353
Naproxen SodiumNAPROXEN SODIUMCVS1042b202-e8ee-1839-e063-6294a90ac90b2025-12-19WarningsExact identifier
application applno (ANDA): 091353
application number: ANDA091353
Naproxen SodiumNAPROXEN SODIUMCVS10429d07-de96-5542-e063-6294a90a73712025-12-19WarningsExact identifier
application applno (ANDA): 091353
application number: ANDA091353
Dr Simi All Day Pain ReliefNAPROXEN SODIUMFarmacias De Similares TX LLC3c6d4bb5-eb6f-944b-e063-6294a90ae8de2025-08-15WarningsExact identifier
application applno (ANDA): 091353
application number: ANDA091353
Naproxen SodiumNAPROXEN SODIUMBi-Mart6d5cecc9-5095-477b-bfc7-45b6e7e689f02025-03-01WarningsExact identifier
application applno (ANDA): 091353
application number: ANDA091353
NAPROXEN SODIUMNAPROXEN SODIUMSPIRIT PHARMACEUTICALS,LLCa690dc39-95f2-4853-a291-05d7dc9a15512024-12-30WarningsExact identifier
application applno (ANDA): 091353
application number: ANDA091353
Pain ReliefNAPROXEN SODIUMGobrands, Incae4bfa8c-ae41-4fcd-b584-872cc4d376832024-12-20WarningsExact identifier
application applno (ANDA): 091353
application number: ANDA091353
PROXEN NP 660NAPROXEN SODIUMOPMX LLC09990b2f-202e-b4df-e063-6394a90a055b2023-12-27WarningsExact identifier
application applno (ANDA): 091353
application number: ANDA091353
Naproxen SodiumNAPROXEN SODIUMGranules India Ltd95ba1722-60ed-4a83-9f26-50c4de8cf1802023-02-06WarningsExact identifier
application applno (ANDA): 091353
application number: ANDA091353
All Day Pain ReliefNAPROXEN SODIUM TABLETS, 220 MGHealthLife of USA LLC7b0cb91e-5465-40ef-9f82-919f7d984f172017-06-01WarningsExact identifier
application applno (ANDA): 091353
application number: ANDA091353

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
46994-665-50469940665501 BOTTLE in 1 CARTON (46994-665-50) > 50 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE1 bottle2022-08-240000-00-00NoNoCurrent